Related references
Note: Only part of the references are listed.PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced Melanomas
Jeremy Perottet et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Sandra Martinez-Morilla et al.
LABORATORY INVESTIGATION (2020)
Bridging Genomics and Tissue Pathology
Nikhil Rao et al.
Genetic Engineering & Biotechnology News (2020)
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer
Cecilia Bozzetti et al.
IMMUNOTHERAPY (2020)
Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas
Reuben Moncada et al.
NATURE BIOTECHNOLOGY (2020)
Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity
Lena Voith von Voithenberg et al.
NUCLEIC ACIDS RESEARCH (2020)
High-dimensional immune-profiling in cancer: implications for immunotherapy
Samuel Chuah et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Cell Atlas technologies and insights into tissue architecture
Anna Wilbrey-Clark et al.
BIOCHEMICAL JOURNAL (2020)
Spatially Resolved Transcriptomes-Next Generation Tools for Tissue Exploration
Michaela Asp et al.
BIOESSAYS (2020)
Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner
Emily F. Willis et al.
CELL (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non-Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Jon Zugazagoitia et al.
CLINICAL CANCER RESEARCH (2020)
Digital spatial profiling application in breast cancer: a user's perspective
Amy E. McCart Reed et al.
VIRCHOWS ARCHIV (2020)
Digital quantitative assessment of PD-L1 using digital spatial profiling
Swati Gupta et al.
LABORATORY INVESTIGATION (2020)
Spatial-omics: Novel approaches to probe cell heterogeneity and extracellular matrix biology
Grace C. Bingham et al.
MATRIX BIOLOGY (2020)
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Christopher R. Merritt et al.
NATURE BIOTECHNOLOGY (2020)
Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology
Ye Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Wei Chang Colin Tan et al.
CANCER COMMUNICATIONS (2020)
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Andrew L. Ji et al.
CELL (2020)
Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies
Natasja L. de Vries et al.
FRONTIERS IN ONCOLOGY (2020)
Collapsing Glomerulopathy in a Patient With COVID-19
Christopher P. Larsen et al.
KIDNEY INTERNATIONAL REPORTS (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Placing RNA in context and space - methods for spatially resolved transcriptomics
Carina Strell et al.
FEBS JOURNAL (2019)
Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH
Chee-Huat Linus Eng et al.
NATURE (2019)
Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?
Paul Hofman et al.
CANCERS (2019)
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management
Sounak Gupta et al.
MODERN PATHOLOGY (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Spatial transcriptomics coming of age
Darren J. Burgess
NATURE REVIEWS GENETICS (2019)
Single-cell genomics identifies cell type-specific molecular changes in autism
Dmitry Velmeshev et al.
SCIENCE (2019)
Single-Cell RNA-Seq Technologies and Related Computational Data Analysis
Geng Chen et al.
FRONTIERS IN GENETICS (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling
Maria I. Toki et al.
CLINICAL CANCER RESEARCH (2019)
The influence of microenvironment on tumor immunotherapy
Jieying Zhang et al.
FEBS JOURNAL (2019)
DIGITAL SPATIAL PROFILING OF IMMUNE MARKERS IN R-CHOP TREATED DIFFUSE LARGE B-CELL LYMPHOMA REVEALS A DOMINANT PROGNOSTIC SIGNIFICANCE OF M2 MACROPHAGE INFILTRATION
A.D. Jeyasekharan et al.
HEMATOLOGICAL ONCOLOGY (2019)
Multiplexed detection of RNA using MERFISH and branched DNA amplification
Chenglong Xia et al.
SCIENTIFIC REPORTS (2019)
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
Steve Lu et al.
JAMA ONCOLOGY (2019)
Spatial transcriptome profiling by MERFISH reveals subcellular RNA compartmentalization and cell cycle-dependent gene expression
Chenglong Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Single-Cell Analysis Reveals Regulatory Gene Expression Dynamics Leading to Lineage Commitment in Early T Cell Development
Wen Zhou et al.
CELL SYSTEMS (2019)
Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma
Melanie Boxberg et al.
JOURNAL OF IMMUNOLOGY (2019)
New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue
Jeremie Decalf et al.
JOURNAL OF PATHOLOGY (2019)
Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells
Don-Marc Franchini et al.
CELL REPORTS (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Preclinical CAR-T cell target safety, biodistribution, and tumor infiltration analysis using in situ hybridization technology.
Helly Pimentel et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
Swati Gupta et al.
NPJ BREAST CANCER (2019)
Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression
Maria Tretiakova et al.
MODERN PATHOLOGY (2018)
Cancer transcriptome profiling at the juncture of clinical translation
Marcin Cieslik et al.
NATURE REVIEWS GENETICS (2018)
Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization
Mohamad Mazen Gafeer et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
Dynamics and Spatial Genomics of the Nascent Transcriptome by Intron seqFISH
Sheel Shah et al.
CELL (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms
Christina Koppel et al.
MODERN PATHOLOGY (2018)
DKK2 imparts tumor immunity evasion through beta-catenin-independent suppression of cytotoxic immune-cell activation
Qian Xiao et al.
NATURE MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters
Manuel A. Silva et al.
PLOS ONE (2018)
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Emelie Berglund et al.
NATURE COMMUNICATIONS (2018)
Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma
De-Xiu Bu et al.
Oncotarget (2018)
Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry
Daniel Schulz et al.
CELL SYSTEMS (2018)
An integrated automated multispectral imaging technique that simultaneously detects and quantitates viral RNA and immune cell protein markers in fixed sections from Epstein-Barr virus-related tumours
Yu Ting Felicia Wee et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2018)
Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma
Kim Thrane et al.
CANCER RESEARCH (2018)
A method for manual and automated multiplex RNAscope in situ hybridization and immunocytochemistry on cytospin samples
Sara Chan et al.
PLOS ONE (2018)
Data-Driven Discovery of Immune Contexture Biomarkers
Lars Ole Schwen et al.
FRONTIERS IN ONCOLOGY (2018)
RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples
Chenglin Wu et al.
COMMUNICATIONS BIOLOGY (2018)
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
Douglas B. Johnson et al.
JCI INSIGHT (2018)
The role of the tumour microenvironment in immunotherapy
Stephan Gasser et al.
ENDOCRINE-RELATED CANCER (2017)
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
Hui Yu et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guerin therapy for intermediate- and high-risk non-muscleinvasive bladder cancer
Esmee I. M. L. Liem et al.
MEDICAL ONCOLOGY (2017)
Is autoimmunity the Achilles' heel of cancer immunotherapy?
Carl H. June et al.
NATURE MEDICINE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization
Laura Annaratone et al.
Oncotarget (2017)
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
Manuela Terranova-Barberio et al.
ONCOTARGET (2017)
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
Ashraful Haque et al.
GENOME MEDICINE (2017)
PD-L1 expression in lung adenosquamous carcinomas compared with the more common variants of non-small cell lung cancer
Xiaohua Shi et al.
SCIENTIFIC REPORTS (2017)
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
Soren Muller et al.
GENOME BIOLOGY (2017)
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
M. F. Sanmamed et al.
ANNALS OF ONCOLOGY (2017)
ST Pipeline: an automated pipeline for spatial mapping of unique transcripts
Jose Fernandez Navarro et al.
BIOINFORMATICS (2017)
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Aleix Prat et al.
CANCER RESEARCH (2017)
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
Jennifer H. Yearley et al.
CLINICAL CANCER RESEARCH (2017)
Fluorescence in situ hybridization in surgical pathology: principles and applications
Liang Cheng et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)
Willy Hugo et al.
CELL (2017)
Fourth Generation of Next-Generation Sequencing Technologies: Promise and Consequences
Rongqin Ke et al.
HUMAN MUTATION (2016)
Fully Automated RNAscope In Situ Hybridization Assays for Formalin-Fixed Paraffin-Embedded Cells and Tissues
Courtney M. Anderson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
What does PD-L1 positive or negative mean?
Antoni Ribas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Coming of age: ten years of next-generation sequencing technologies
Sara Goodwin et al.
NATURE REVIEWS GENETICS (2016)
High-throughput single-cell gene-expression profiling with multiplexed error-robust fluorescence in situ hybridization
Jeffrey R. Moffitt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
Patrik L. Stahl et al.
SCIENCE (2016)
Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significance
Jiajia Yuan et al.
ONCOTARGET (2016)
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma
Maria Libera Ascierto et al.
CANCER IMMUNOLOGY RESEARCH (2016)
PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker
Lei Guo et al.
SPRINGERPLUS (2016)
An automated approach to prepare tissue-derived spatially barcoded RNA-sequencing libraries
Anders Jemt et al.
SCIENTIFIC REPORTS (2016)
Spatially resolved, highly multiplexed RNA profiling in single cells
Kok Hao Chen et al.
SCIENCE (2015)
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
Ziming Du et al.
ONCOTARGET (2015)
US Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive
Shakun M. Malik et al.
CLINICAL CANCER RESEARCH (2014)
Multiplexed ion beam imaging of human breast tumors
Michael Angelo et al.
NATURE MEDICINE (2014)
Onco-proteogenomics: cancer proteomics joins forces with genomics
Javier A. Alfaro et al.
NATURE METHODS (2014)
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
Charlotte Giesen et al.
NATURE METHODS (2014)
Single-cell in situ RNA profiling by sequential hybridization
Eric Lubeck et al.
NATURE METHODS (2014)
FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements
Dickran Kazandjian et al.
ONCOLOGIST (2014)
Single-molecule fluorescence in situ hybridization: Quantitative imaging of single RNA molecules
Sunjong Kwon
BMB REPORTS (2013)
Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma
Zhen Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Single-molecule mRNA detection and counting in mammalian tissue
Anna Lyubimova et al.
NATURE PROTOCOLS (2013)
In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Z. Jehan et al.
CURRENT MEDICINAL CHEMISTRY (2012)
RNAscope A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded Tissues
Fay Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guerin Therapy for Bladder Cancer: Results of a Prospective Trial
Ashish M. Kamat et al.
JOURNAL OF UROLOGY (2012)
Imaging individual mRNA molecules using multiple singly labeled probes
Arjun Raj et al.
NATURE METHODS (2008)
Stochastic mRNA synthesis in mammalian cells
Arjun Raj et al.
PLOS BIOLOGY (2006)
Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia
AP Landstrom et al.
LEUKEMIA & LYMPHOMA (2006)
The biological limitations of transcriptomics in elucidating stress and stress responses
ME Feder et al.
JOURNAL OF EVOLUTIONARY BIOLOGY (2005)
Share Paper
